Published in OBGYN and Reproduction Week, August 4th, 2003
After the decision is made, the European member states usually get the official certificate of approval within 3 months. The rollout of the pan European launch for Angeliq will begin this autumn. Schering received the first European approval for Angeliq in December 2002 in the Netherlands, which served as the reference member state for the Mutual Recognition Procedure (MRP).
Angeliq is a low-dose combination preparation and the only HRT product...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of OBGYN and Reproduction Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.